Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH)

被引:17
作者
Bacher, U [1 ]
Kern, W [1 ]
Schoch, C [1 ]
Hiddemann, W [1 ]
Haferlach, T [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Internal Med 3, Lab Leukemia Diagnost, D-81377 Munich, Germany
关键词
CLL/PL; cytomorphology; interphase fluorescence in situ hybridization; prolymphocytes;
D O I
10.1007/s00277-004-0869-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although interphase fluorescence in situ hybridization (FISH) is routinely used in chronic lymphocytic leukemia (CLL), differences in the chromosomal pattern with respect to morphological subtypes of CLL (typical CLL, CLL/PL, PLL) are still under debate. We studied 153 patients with CLL and correlated cytomorphology on peripheral blood stains with FISH analysis and other prognostic markers. The percentage of prolymphocytes was calculated as a continuous variable and followed published thresholds in parallel while being correlated to FISH analysis. Higher percentages of prolymphocytes were associated significantly with deletion of 17p13. Deletion of 17p13 was most frequently observed in patients with more than 30% prolymphocytes. Trisomy 12 was found mainly in cases with 6-30% prolymphocytes. The percentage of prolymphocytes did not correlate with deletions of 11q23 or with 13q14 abnormalities. In conclusion, we suggest that further research focus on the percentage of prolymphocytes in CLL. Doing so, biologically relevant thresholds for the percentages of prolymphocytes in the peripheral blood and their association to underlying genetic markers could be investigated together with other biologically and especially prognostic markers.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 32 条
[11]  
Frater JL, 2001, AM J CLIN PATHOL, V116, P655
[12]   In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients [J].
Geisler, CH ;
Philip, P ;
Christensen, BE ;
Hou-Jensen, K ;
Pedersen, NT ;
Jensen, OM ;
Thorling, K ;
Andersen, E ;
Birgens, HS ;
Drivsholm, A ;
Ellegaard, J ;
Larsen, JK ;
Plesner, T ;
Brown, P ;
Andersen, PK ;
Hansen, MM .
LEUKEMIA RESEARCH, 1997, 21 (11-12) :1011-1023
[13]  
Hallek M, 1999, BLOOD, V93, P1732
[14]   Serum beta 2-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma [J].
Hallek, M ;
Wanders, L ;
Ostwald, M ;
Busch, R ;
Senekowitsch, R ;
Stern, S ;
Schick, HD ;
KuhnHallek, I ;
Emmerich, B .
LEUKEMIA & LYMPHOMA, 1996, 22 (5-6) :439-447
[15]   A multicentric study of 41 cases of B-prolymphocytic leukemia: Two evolutive forms [J].
Hercher, C ;
Robain, M ;
Davi, F ;
Garand, R ;
Flandrin, G ;
Valensi, F ;
Vandeputte, H ;
Albert, A ;
Maynadie, M ;
Troussard, X ;
Simon, GH ;
Lespinasse, J ;
Portefaix, G ;
Merle-Beral, H .
LEUKEMIA & LYMPHOMA, 2001, 42 (05) :981-+
[16]   Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course [J].
Hjalmar, V ;
Hast, R ;
Kimby, E .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (03) :127-134
[17]   Atypical lymphocytes in B-cell chronic lymphocytic leukemia and trisomy 12 studied by conventional staining combined with fluorescence in situ hybridization [J].
Hjalmar, V ;
Kimby, E ;
Matutes, E ;
Sundström, C ;
Wallvik, J ;
Hast, R .
LEUKEMIA & LYMPHOMA, 2000, 37 (5-6) :571-576
[18]  
Jaffe ES., 2001, PATHOLOGY GENETICS T
[19]   PROGNOSTIC SUBGROUPS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA DEFINED BY SPECIFIC CHROMOSOMAL-ABNORMALITIES [J].
JULIUSSON, G ;
OSCIER, DG ;
FITCHETT, M ;
ROSS, FM ;
STOCKDILL, G ;
MACKIE, MJ ;
PARKER, AC ;
CASTOLDI, GL ;
CUNEO, A ;
KNUUTILA, S ;
ELONEN, E ;
GAHRTON, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (11) :720-724
[20]   p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis [J].
Lens, D ;
Dyer, MJS ;
Garcia-Marco, JM ;
De Schouwer, PJJC ;
Hamoudi, RA ;
Jones, D ;
Farahat, N ;
Matutes, E ;
Catovsky, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (04) :848-857